| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2017 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 4,4 M € | +48.7% | 3,0 M € | -1.8% | 3,0 M € | +203.3% | -2,9 M € | -259.4% | 1,9 M € | +610.1% | 260,6 k € | +362.2% | -99,4 k € | +82.3% | -561,9 k € | |
| EBITDA | 3,1 M € | +71.4% | 1,8 M € | -7.9% | 2,0 M € | +145.5% | -4,3 M € | -567.2% | 926,7 k € | +550.4% | -205,7 k € | +41.2% | -349,6 k € | +44.9% | -634,5 k € | |
| Operating profit | 137,0 k € | +114.7% | -930,8 k € | -471.0% | -163,0 k € | +97.3% | -6,1 M € | -817.2% | -668,6 k € | +38.3% | -1,1 M € | +4.8% | -1,1 M € | -68.6% | -675,4 k € | |
| Profit/loss | 259,6 k € | +134.6% | -750,9 k € | -1053.1% | 78,8 k € | +101.3% | -6,1 M € | -868.7% | -633,4 k € | +39.8% | -1,1 M € | +0.7% | -1,1 M € | -43.7% | -738,2 k € | |
| Equity | 1,9 M € | +16.3% | 1,6 M € | -32.0% | 2,3 M € | +3.5% | 2,3 M € | +107.9% | 1,1 M € | -36.7% | 1,7 M € | -37.1% | 2,7 M € | +579.2% | -571,6 k € | |
| Total assets | 5,9 M € | -25.2% | 7,9 M € | -5.3% | 8,4 M € | +21.3% | 6,9 M € | +124.8% | 3,1 M € | +0.4% | 3,1 M € | +5.0% | 2,9 M € | +557.7% | 443,2 k € | |
| Cash | 2,8 M € | -27.2% | 3,9 M € | -20.2% | 4,8 M € | -8.3% | 5,3 M € | +123.6% | 2,4 M € | -12.9% | 2,7 M € | — | — | |||
| Debts | 615,9 k € | -76.9% | 2,7 M € | +23.9% | 2,2 M € | -53.6% | 4,6 M € | +135.8% | 2,0 M € | +663.2% | 257,8 k € | +46.2% | 176,4 k € | -81.5% | 952,3 k € | |
| Staff | 12,2 | 11,5 | 11,4 | 12,3 | 10,6 | 7,1 | 3,8 | — | ||||||||
Public limited company · Gent · incorporated on 23/12/2016 · 12,2 ETP
Public limited company profitable and well capitalised. Cash position declining (-27.2%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
S-Biomedic is a Public limited company incorporated in 2016. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Gent. It employs on average 12,2 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette